Patent · US Expired

Smad6 and uses thereof

US6534476B2 · kind B2 · utility

20Cited by

1References

12Claims

0Family size

Assignee

Japanese Foundation for Cancer Research · JP

Inventors

Kohei Miyazono · Tokyo, JP
Masahiro Kawabata · Tokyo, JP

Key dates

Filing date	Aug 7, 2001
Grant date	Mar 18, 2003
Priority date	—
Expiry date	Aug 7, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention includes nucleic acids encoding the Smad6 protein, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products for using such nucleic acids and polypeptides also are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.